Mineralys Therapeutics (MLYS) Return on Assets [ROA] (2023 - 2026)
Mineralys Therapeutics (MLYS) recorded Return on Assets [ROA] of -59.63% in Q3 2026, down 21.18 percentage points from -38.45% a year earlier and down 4.12 percentage points from the prior quarter.
Powered by 
Analysis
Mineralys Therapeutics (MLYS) Return on Assets [ROA] (2023 - 2026) Analysis & Trends
For FY2025, Mineralys Therapeutics reported Return on Assets [ROA] of -39.32%, up 44.78 percentage points from FY2024.
- Across earlier years, Return on Assets [ROA] came in at -84.10% in FY2024 (-37.85 pp) and -46.25% in FY2023.
- The Q3 2026 figure is the lowest quarterly Return on Assets [ROA] since Q1 2025.
- On a year-over-year basis, Return on Assets [ROA] rose in four of the last eight quarters, with an average year-over-year change of -0.26 percentage points.
- Peak year-over-year performance for Return on Assets [ROA] in the last five years was a gain of 54.78 percentage points in Q4 2025, against a drop of 49.16 percentage points in Q4 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at -55.51% (Q2 2026), -25.45% (Q1 2026) and -26.38% (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 19.00% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 8.08% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 7.32% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 1.87% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 9.36% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 9.80% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -7.67% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 2.00% |
| 10 | Mineralys Therapeutics | 1.37 Bn | -1.21 Bn | - | -59.63% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -59.63% |
| Jun 30, 2026 | -55.51% |
| Mar 31, 2026 | -25.45% |
| Dec 31, 2025 | -26.38% |
| Sep 30, 2025 | -38.45% |
| Jun 30, 2025 | -58.80% |
| Mar 31, 2025 | -71.85% |
| Dec 31, 2024 | -81.16% |
| Sep 30, 2024 | -57.38% |
| Jun 30, 2024 | -40.41% |
| Mar 31, 2024 | -35.09% |
| Dec 31, 2023 | -31.99% |
| Sep 30, 2023 | -23.54% |
| Jun 30, 2023 | -16.10% |
| Mar 31, 2023 | -18.46% |
API Access
Mineralys Therapeutics Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=MLYS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "MLYS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=MLYS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();